Vident Investment Advisory’s LianBio American Depositary Shares LIAN Stock Holding History

Vident Investment Advisory’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,778	Closed	-$54.4K	–	1357
2023 Q1	$54.4K	Sell	27,778 -838	-3%	-$1.74K	﹤0.01%	1200
2022 Q4	$46.9K	Hold	28,616	–	–	﹤0.01%	1154
2022 Q3	$57K	Buy	28,616 +8,703	+44%	+$20.8K	﹤0.01%	1092
2022 Q2	$43K	Hold	19,913	–	–	﹤0.01%	1246
2022 Q1	$74K	Buy	+19,913	New	+$82.2K	﹤0.01%	1241

Other funds holding LIAN

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Vident Investment Advisory's LIAN Position: Q2 2023 in Review

Vident Investment Advisory sold out of LianBio American Depositary Shares (LIAN) in Q2 2023, closing a stake of 27,778 shares — an estimated $54.4K sold.

Vident Investment Advisory first reported a position in LIAN in Q1 2022 and held it in 5 quarters. The position peaked at $74K in Q1 2022. 39 funds tracked by Wall St. Rank hold LIAN as of Q2 2023.

Vident Investment Advisory reported no remaining LianBio American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Vident Investment Advisory sold 27,778 LianBio American Depositary Shares shares in Q2 2023, an estimated $54.4K.
Vident Investment Advisory first reported a position in LianBio American Depositary Shares in Q1 2022 and held it in 5 quarters.
Vident Investment Advisory's LianBio American Depositary Shares position peaked at $74K in Q1 2022.
39 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q2 2023.

Based on Vident Investment Advisory's 13F filing for Q2 2023, filed 11 Aug 2023.